Format
Items per page
Sort by

Send to:

Choose Destination

Results: 1 to 20 of 35

References for PMC Articles for PubMed (Select 21839795)

1.

Norovirus-host interaction: multi-selections by human histo-blood group antigens.

Tan M, Jiang X.

Trends Microbiol. 2011 Aug;19(8):382-8. doi: 10.1016/j.tim.2011.05.007. Epub 2011 Jun 24.

2.

Universal vaccine based on ectodomain of matrix protein 2 of influenza A: Fc receptors and alveolar macrophages mediate protection.

El Bakkouri K, Descamps F, De Filette M, Smet A, Festjens E, Birkett A, Van Rooijen N, Verbeek S, Fiers W, Saelens X.

J Immunol. 2011 Jan 15;186(2):1022-31. doi: 10.4049/jimmunol.0902147. Epub 2010 Dec 17.

3.

Norovirus P particle, a novel platform for vaccine development and antibody production.

Tan M, Huang P, Xia M, Fang PA, Zhong W, McNeal M, Wei C, Jiang W, Jiang X.

J Virol. 2011 Jan;85(2):753-64. doi: 10.1128/JVI.01835-10. Epub 2010 Nov 10.

4.

Norovirus gastroenteritis, carbohydrate receptors, and animal models.

Tan M, Jiang X.

PLoS Pathog. 2010 Aug 26;6(8):e1000983. doi: 10.1371/journal.ppat.1000983. Review. No abstract available.

5.

Human antibodies reveal a protective epitope that is highly conserved among human and nonhuman influenza A viruses.

Grandea AG 3rd, Olsen OA, Cox TC, Renshaw M, Hammond PW, Chan-Hui PY, Mitcham JL, Cieplak W, Stewart SM, Grantham ML, Pekosz A, Kiso M, Shinya K, Hatta M, Kawaoka Y, Moyle M.

Proc Natl Acad Sci U S A. 2010 Jul 13;107(28):12658-63. doi: 10.1073/pnas.0911806107. Epub 2010 Jul 1.

6.

Genetic and phenotypic characterization of GII-4 noroviruses that circulated during 1987 to 2008.

Yang Y, Xia M, Tan M, Huang P, Zhong W, Pang XL, Lee BE, Meller J, Wang T, Jiang X.

J Virol. 2010 Sep;84(18):9595-607. doi: 10.1128/JVI.02614-09. Epub 2010 Jun 30.

7.

An M2e-based multiple antigenic peptide vaccine protects mice from lethal challenge with divergent H5N1 influenza viruses.

Zhao G, Lin Y, Du L, Guan J, Sun S, Sui H, Kou Z, Chan CC, Guo Y, Jiang S, Zheng BJ, Zhou Y.

Virol J. 2010 Jan 18;7:9. doi: 10.1186/1743-422X-7-9.

8.

Conservation of carbohydrate binding interfaces: evidence of human HBGA selection in norovirus evolution.

Tan M, Xia M, Chen Y, Bu W, Hegde RS, Meller J, Li X, Jiang X.

PLoS One. 2009;4(4):e5058. doi: 10.1371/journal.pone.0005058. Epub 2009 Apr 1.

9.

Noroviral P particle: structure, function and applications in virus-host interaction.

Tan M, Fang P, Chachiyo T, Xia M, Huang P, Fang Z, Jiang W, Jiang X.

Virology. 2008 Dec 5;382(1):115-23. doi: 10.1016/j.virol.2008.08.047. Epub 2008 Oct 16.

10.

Universal influenza A M2e-HBc vaccine protects against disease even in the presence of pre-existing anti-HBc antibodies.

De Filette M, Martens W, Smet A, Schotsaert M, Birkett A, LondoƱo-Arcila P, Fiers W, Saelens X.

Vaccine. 2008 Dec 2;26(51):6503-7. doi: 10.1016/j.vaccine.2008.09.038.

PMID:
18835315
11.

Elucidation of strain-specific interaction of a GII-4 norovirus with HBGA receptors by site-directed mutagenesis study.

Tan M, Xia M, Cao S, Huang P, Farkas T, Meller J, Hegde RS, Li X, Rao Z, Jiang X.

Virology. 2008 Sep 30;379(2):324-34. doi: 10.1016/j.virol.2008.06.041. Epub 2008 Aug 8.

12.

Therapeutic potential of a fully human monoclonal antibody against influenza A virus M2 protein.

Wang R, Song A, Levin J, Dennis D, Zhang NJ, Yoshida H, Koriazova L, Madura L, Shapiro L, Matsumoto A, Yoshida H, Mikayama T, Kubo RT, Sarawar S, Cheroutre H, Kato S.

Antiviral Res. 2008 Nov;80(2):168-77. doi: 10.1016/j.antiviral.2008.06.002. Epub 2008 Jul 1.

PMID:
18598723
13.

An influenza A vaccine based on tetrameric ectodomain of matrix protein 2.

De Filette M, Martens W, Roose K, Deroo T, Vervalle F, Bentahir M, Vandekerckhove J, Fiers W, Saelens X.

J Biol Chem. 2008 Apr 25;283(17):11382-7. doi: 10.1074/jbc.M800650200. Epub 2008 Feb 5.

14.

Norovirus gastroenteritis, increased understanding and future antiviral options.

Tan M, Jiang X.

Curr Opin Investig Drugs. 2008 Feb;9(2):146-51. Review.

PMID:
18246517
15.

Potent immunogenicity and efficacy of a universal influenza vaccine candidate comprising a recombinant fusion protein linking influenza M2e to the TLR5 ligand flagellin.

Huleatt JW, Nakaar V, Desai P, Huang Y, Hewitt D, Jacobs A, Tang J, McDonald W, Song L, Evans RK, Umlauf S, Tussey L, Powell TJ.

Vaccine. 2008 Jan 10;26(2):201-14. Epub 2007 Nov 20.

PMID:
18063235
16.

Norovirus-host interaction: implications for disease control and prevention.

Tan M, Jiang X.

Expert Rev Mol Med. 2007 Jul 11;9(19):1-22. Review.

PMID:
17623487
17.

Controlling influenza virus replication by inhibiting its proton channel.

Pinto LH, Lamb RA.

Mol Biosyst. 2007 Jan;3(1):18-23. Epub 2006 Nov 22. Review.

PMID:
17216051
18.

Influenza A virus infection engenders a poor antibody response against the ectodomain of matrix protein 2.

Feng J, Zhang M, Mozdzanowska K, Zharikova D, Hoff H, Wunner W, Couch RB, Gerhard W.

Virol J. 2006 Dec 6;3:102.

20.
Format
Items per page
Sort by

Send to:

Choose Destination

Supplemental Content

Write to the Help Desk